FORT LAUDERDALE, Fla., May 14, 2003 (PRIMEZONE) -- Tekron, Inc. (OTCBB:TKRN) today announced that it has entered into a Letter of Intent with Jacobson Resonance Enterprises Inc.
About Tekron, Inc.
Tekron, Inc. aims to market next-generation medical devices and technologies that have the ability to revolutionize medical care around the world. In this instance, the unique, next-generation device and technology is based on Jacobson Resonance.
"I look forward to working with Dr. Jacobson and his fine management team," said Luigi Brun, President of Tekron Inc., "starting with Taiwan, Tekron will diligently strive to implement this amazing technology throughout Asia."
About Jacobson Resonance Enterprises, Inc.
JRSE is an emerging worldwide leader in magnetic resonance technology, whose main focus is on the eradication of human suffering. The Company's technology base has the potential for multiple industry applications including the fields of medicine, food and beverage, pharmaceuticals, construction and the environment.
This information contains certain forward-looking statements and information relating to the Company that are based on the beliefs of the Company or management as well as assumptions made by and information currently available to the Company or management. When used in this document, the words "anticipate," "believe," "estimate," "expect" and "intend" and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected or intended. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein.